U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Kokolo M, Tinmouth A, Fergusson D. Addendum to a Systematic Review of Clinical, Laboratory and Safety Outcomes Associated with Use of Octaplas in Multiple Clinical Indications: Pilot Project [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 May.

Cover of Addendum to a Systematic Review of Clinical, Laboratory and Safety Outcomes Associated with Use of Octaplas in Multiple Clinical Indications

Addendum to a Systematic Review of Clinical, Laboratory and Safety Outcomes Associated with Use of Octaplas in Multiple Clinical Indications: Pilot Project [Internet].

Show details

REFERENCES

1.
Vaara I, Nilsson CD. [SD plasma safer than fresh-frozen plasma. Comparative studies show advantages of industrially produced plasma] [Swedish] Lakartidningen. 2010;107(3):106–107. [PubMed: 20225684]
2.
Scully M, Longair I, Flynn M, Berryman J, Machin SJ. Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang. 2007;93(2):154–158. [PubMed: 17683359]
3.
Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med. 2007;33:S17–S21. [PubMed: 17676435]
4.
Callum JL, Pinkerton PH. Bloody easy: blood transfusions, blood alternatives and transfusion reactions: a guide to transfusion medicine. 2nd ed. Toronto: Sunnybrook and Women's College Health Sciences Centre; 2005.
5.
Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul & Fibrinolysis. 2003;14(3):283–287. [PubMed: 12695752]
6.
Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med. 2004;14(1):39–44. [PubMed: 15043592]
7.
Beeck H, Hellstern P. In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma. Vox Sang. 1998;74 Suppl 1:219–223. [PubMed: 9789532]
8.
Buchta C, Felfernig M, Hocker P, Macher M, Kormoczi GF, Quehenberger P, Heinzl H, Knobl P. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Vox Sang. 2004;87(3):182–186. [PubMed: 15569070]
9.
Heger A, Romisch J, Svae TE. Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing. Transfus Apher Sci. 2005;33(3):257–267. [PubMed: 16203177]
10.
Zeiler T, Wittmann G, Zimmermann R, Hintz G, Huhn D, Riess H. The effect of virus inactivation on coagulation factors in therapeutic plasma [comment] Br J Haematol. 2000;111(3):986–987. [PubMed: 11122166]
11.
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. [PMC free article: PMC2707599] [PubMed: 19621072]
12.
Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309(6964):1286–1291. [PMC free article: PMC2541778] [PubMed: 7718048]
13.
Krusius T, Auvinen M-K, Nikkinen L. Introduction of octaplas- in clinical use decreased the rate of severe adverse reactions [abstract] Vox Sang. 2009;96 Supplement1:33.
14.
Piccin A, Cronin M, Murphy C, Eakins E, Lawlor E. Transfusion associated circulatory overload (TACO) incidence and risk factors. Poster session presented at: 51st American Society of Hematology Annual Meeting and Exposition; 2009 Dec 5–8; New Orleans, LA.
15.
Bass G, Honan D. Octaplas is not equivalent to fresh frozen plasma in the treatment of acute angioedema. Eur J Anaesthesiol. 2007;24(12):1062–1063. [PubMed: 18210660]
16.
De Silvestro G, Bagatella P, Tison T, Quaino V, Carraro P, Tenderini ML, Lazzaro A, Marotti A. Virus-inactivated plasma - Plasmasafe: a one-year experience. Blood Transfus. 2007;5(3):134–142. [PMC free article: PMC2535896] [PubMed: 19204766]
17.
Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. CMAJ. 1997;156(11):S1–S24.
18.
O'Shaughnessy DF, Atterbury C, Bolton MP, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126(1):11–28. [PubMed: 15198728]
19.
Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325(6):393–397. [PubMed: 2062330]
Copyright © 2011 CADTH.

This report may be reproduced for non-commercial purposes only and provided appropriate credit is given to CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK174529
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (642K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...